Malaria vaccine shows 87% efficacy in clinical trial

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

The novel, genetically attenuated whole-parasite PfSPZ-LARC2 Vaccine for malaria achieved an 87% efficacy rate in preventing infection during a recent phase 1 trial.

Read original article on Medical Xpress - latest medical and health news stories →